BRIEF published on 11/19/2025 at 23:05, 3 months 27 days ago Medicure's Q3 2025 Financial Results Reflect Revenue Growth Despite Net Loss Revenue Growth Marley Drug Net Loss AGGRASTAT® Sales Medicure Financial Results
PRESS RELEASE published on 11/19/2025 at 23:00, 3 months 27 days ago Medicure Reports Financial Results for Quarter Ended September 30, 2025 Medicure Inc. reports Q3 2025 results with total net revenue of $8.2 million, an overview of financial performance and key highlights Financial Performance Medicure Inc. Net Revenue Q3 2025 Results Highlights
BRIEF published on 11/13/2025 at 23:35, 4 months 3 days ago Medicure to Announce Q3 2025 Financial Results on November 20 Financial Results Conference Call Medicure Inc. U.S. Pharmaceuticals AGGRASTAT® And ZYPITAMAG®
PRESS RELEASE published on 11/13/2025 at 23:30, 4 months 3 days ago Medicure To Present Financial Results on November 20, 2025 Call at 8:30 AM ET for Quarter Ended September 30, 2025 Medicure Inc. will present Financial Results for Q3 2025 on November 20, 2025, focusing on pharmaceutical development and commercialization in the U.S. market Financial Results Conference Call Pharmaceuticals Medicure Inc. Healthcare Products
BRIEF published on 08/20/2025 at 23:35, 6 months 27 days ago Medicure Reports Q2 2025 Financial Results Financial Results Net Loss Net Revenue Research Investment Pharmaceutical Business
PRESS RELEASE published on 08/20/2025 at 23:30, 6 months 27 days ago Medicure Reports Financial Results for Quarter Ended June 30, 2025 Medicure Inc. reports Q2 2025 financial results, including increased revenue from Marley Drug and ZYPITAMAG(R), and enhanced adjusted EBITDA. Find full details at www.medicure.com Financial Results Medicure Inc. Marley Drug ZYPITAMAG Q2 2025
BRIEF published on 08/18/2025 at 23:35, 6 months 29 days ago Medicure to Announce Q2 2025 Financial Results via Conference Call Financial Results Conference Call Pharmaceuticals Medicure Q2 2025
PRESS RELEASE published on 08/18/2025 at 23:30, 6 months 29 days ago Medicure to Present Financial Results on August 21, 2025 Call at 8:30 am ET for Quarter Ended June 30, 2025 Medicure Inc. to present Financial Results for Q2 2025 on August 21, 2025 via conference call. Operations and products focus detailed Financial Results Conference Call Pharmaceuticals Medicure Inc. Healthcare Products
BRIEF published on 06/17/2025 at 23:05, 8 months 29 days ago Medicure Finalizes Acquisition of West Olympia Pharmacy Acquisition Revenue Growth Pharmaceuticals Pharmacy Medicure
PRESS RELEASE published on 06/17/2025 at 23:00, 8 months 29 days ago Medicure Announces Closing of Purchase Agreement for The Acquisition of West Olympia Pharmacy Medicure Inc. announces acquisition of West Olympia Pharmacy Inc., further boosting direct-to-consumer pharmacy business and sales of ZYPITAMAG(R) and BRENZAVVY(R) Acquisition Medicure Inc. Pharmacy Business ZYPITAMAG(R) BRENZAVVY(R)
Published on 03/17/2026 at 12:00, 10 minutes ago Eagle Plains Partner Refined Energy Completes First Drill Hole at Dufferin West; Second Hole Underway to Test High-Priority EM Conductor
Published on 03/17/2026 at 12:00, 10 minutes ago Galway Hires Jason Flight as VP of Exploration, and Adds a Fourth Drill Rig at Clarence Stream
Published on 03/17/2026 at 11:30, 40 minutes ago Trans Canada Gold Announces Expanded Gold Potential While the Company Prepares for Exploration and Drilling on its Harrison Lake Gold Project
Published on 03/17/2026 at 08:20, 3 hours 50 minutes ago Nano One Advances Candiac LFP Production Capacity Expansion Project, Detailed Engineering & Equipment Procurement
Published on 03/17/2026 at 08:05, 4 hours 5 minutes ago BioNxt Signs Strategic Agreement for Eurasian Commercialization Following Cladribine ODF Patent Grant in Eurasia and Europe
Published on 03/17/2026 at 12:08, 2 minutes ago Notice of the 2026 annual general meeting of Ørsted A/S
Published on 03/17/2026 at 12:02, 7 minutes ago Enapter AG expands global Core Partner network with U.S.-based Total Hydrogen Solutions
Published on 03/17/2026 at 12:00, 10 minutes ago Nebius Group announces proposed private offering of $3.75 billion of convertible senior notes
Published on 03/17/2026 at 07:00, 5 hours 10 minutes ago Invitation to the Extraordinary General Meeting of shareholders
Published on 03/16/2026 at 18:00, 18 hours 10 minutes ago Disclosure of trading in own shares from 09/03/2026 to 13/03/2026
Published on 03/16/2026 at 17:58, 18 hours 12 minutes ago Aéroports de Paris S.A - February 2026 traffic figures
Published on 03/16/2026 at 17:56, 18 hours 13 minutes ago Reporting on share buyback transactions carried out between March 9 and March 13, 2026
